Loomba, Rohit

Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project

Sanyal, A. J., Shankar, S. S., Calle, R. A., Samir, A. E., Sirlin, C. B., Sherlock, S. P., Loomba, R., Fowler, K. J., Dehn, C. A., Heymann, H., et al. (2022) · Nature Medicine

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 56

Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD - an umbrella overview of systematic review of meta-analysis

Xiao, J., Ng, C. H., Chan, K. E., Fu, C., Tay, P., Yong, J. N., Lim, W. H., Tan, D. J. H., Syn, N., Wong, Z. Y., et al. (2023) · Journal of Clinical and Experimental Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 56

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

Qadri, S., Vartiainen, E., Lahelma, M., Porthan, K., Tang, A., Idilman, I. S., Runge, J. H., Juuti, A., Penttilä, A. K., Dabek, J., et al. (2024) · JHEP Reports

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 55

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

Iyer, J. S., Juyal, D., Le, Q., Shanis, Z., Pokkalla, H., Pouryahya, M., Pedawi, A., Stanford-Moore, S. A., Biddle-Snead, C., Carrasco-Zevallos, O., et al. (2024) · Nature Medicine

Liver Disease Diagnosis and TreatmentArtificial Intelligence in Healthcare and Education

Cited by 54

Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma

Zeng, R. W., Ong, C. E. Y., Ong, E. Y. H., Chung, C. H., Lim, W. H., Xiao, J., Danpanichkul, P., Law, J. H., Syn, N., Chee, D., et al. (2024) · Clinical Gastroenterology and Hepatology

Hepatocellular Carcinoma Treatment and PrognosisAlcohol Consumption and Health Effects

Cited by 47

Review Article: GLP ‐1 Receptor Agonists and Glucagon/ GIP / GLP ‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD

Zafer, M., Tavaglione, F., Romero‐Gómez, M., & Loomba, R. (2025) · Alimentary Pharmacology & Therapeutics

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 47

MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH

Loomba, R., Amangurbanova, M., Bettencourt, R., Madamba, E., Siddiqi, H., Richards, L., Behling, C., Sirlin, C. B., Gottwald, M. D., Feng, S., et al. (2024) · Gut

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 43

Treatment Candidacy for Pharmacologic Therapies for NASH

Rowe, I. A., Wong, V. W.-S., & Loomba, R. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 41

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

Thomson, M. J., Serper, M., Khungar, V., Weiss, L. M., Trinh, H., Firpi-Morell, R., Roden, M., Loomba, R., Barritt, A. S., Gazis, D., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLipoproteins and Cardiovascular Health

Cited by 38

MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis

Loomba, R. (2021) · Hepatology

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 36

Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction‐associated steatohepatitis

Harris, S. J., Smith, N., Hummer, B., Schreibman, I. R., Faust, A. J., Geyer, N. R., Chinchilli, V. M., Sciamanna, C., Loomba, R., & Stine, J. G. (2024) · Liver International

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 31

Efficacy of colesevelam on lowering glycemia and lipids

Aggarwal, S., Loomba, R. S., & Arora, R. R. (2012) · Journal of Cardiovascular Pharmacology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 30

Metabolic injury of hepatocytes promotes progression of NAFLD and AALD

Carvalho-Gontijo, R., Han, C., Zhang, L., Zhang, V., Hosseini, M., Mekeel, K., Schnabl, B., Loomba, R., Karin, M., Brenner, D. A., et al. (2022) · Seminars in Liver Disease

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 23

Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy

Loomba, R., Daniel, P. C.-Y. N., Amangurbanova, M., Bettencourt, R., Madamba, E., Siddiqi, H., Richards, L., Gottwald, M. D., Feng, S., Margalit, M., et al. (2026) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 17

Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Loomba, R., Noureddin, M., Kowdley, K., Kohli, A., Sheikh, A., Neff, G., Bhandari, B. R., Gunn, N. T., Caldwell, S., Goodman, Z., et al. (2020) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentOrgan Transplantation Techniques and Outcomes

Cited by 9

Aerobic Exercise Training Leads to MASH Resolution as Defined by the MASH Resolution Index

Channapragada, T., Batra, S., Hummer, B. L., Chinchilli, V. M., Huang, D., Loomba, R., Schreibman, I. R., & Stine, J. G. (2026) · Digestive Diseases and Sciences

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 2